Suppr超能文献

与支气管源性癌相关的胸腔积液中的免疫球蛋白和补体

Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.

作者信息

Kay A B, Smith A F, McGavin C R, Tuft S B

出版信息

J Clin Pathol. 1976 Oct;29(10):887-9. doi: 10.1136/jcp.29.10.887.

Abstract

Levels of IgG, IgA, IgM, the total haemolytic complement (CH50), and the individual components C1q, C3, C4, C6, and C7 were measured in 29 pleural effusions. Of these, 18 were associated with carcinoma of the bronchus and 11 were non-malignant effusions including empyemas. The level of IgG was significantly lower in the malignant group when compared with non-malignant effusions. The usefulness of measurements of IgG with respect to malignant effusions associated with carcinoma of the bronchus requires an expanded study to show whether it has any real diagnostic value. There were no significant differences in other immunoglobulins, the CH50, and individual complement components between the two groups. The identification of total haemolytic activity in the majority of effusions in both groups indicates that all nine components of the classical pathway of complement, including macromolecules such as C1, can be present in pleural fluids.

摘要

对29例胸腔积液患者检测了IgG、IgA、IgM、总溶血补体(CH50)以及补体单个成分C1q、C3、C4、C6和C7的水平。其中,18例与支气管癌相关,11例为非恶性积液,包括脓胸。与非恶性积液相比,恶性组的IgG水平显著降低。对于与支气管癌相关的恶性积液,检测IgG的效用需要进一步扩大研究,以确定其是否具有实际诊断价值。两组之间其他免疫球蛋白、CH50和补体单个成分无显著差异。两组中大多数积液都具有总溶血活性,这表明补体经典途径的所有九个成分,包括C1等大分子,都可能存在于胸液中。

相似文献

1
Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma.
J Clin Pathol. 1976 Oct;29(10):887-9. doi: 10.1136/jcp.29.10.887.
3
Immunoglobulins and complement in migraine.
Cephalalgia. 1983 Jun;3(2):119-23. doi: 10.1046/j.1468-2982.1983.0302119.x.
6
Complement activity in middle ear effusions.
Clin Exp Immunol. 1978 Aug;33(2):340-6.
8
Complement components and their activation products in pleural fluid.
Chest. 1998 Sep;114(3):723-30. doi: 10.1378/chest.114.3.723.

引用本文的文献

1
Potential biomarkers for lung cancer screening.
Transl Lung Cancer Res. 2014 Jun;3(3):139-48. doi: 10.3978/j.issn.2218-6751.2014.06.04.
2
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
J Natl Cancer Inst. 2013 Sep 18;105(18):1385-93. doi: 10.1093/jnci/djt205. Epub 2013 Aug 12.
3
Study of immunoglobulins in pleura and pleural effusions.
Thorax. 1979 Jun;34(3):389-92. doi: 10.1136/thx.34.3.389.

本文引用的文献

1
HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.
J Clin Invest. 1964 Jul;43(7):1372-82. doi: 10.1172/JCI105013.
2
[A micro-method of immuno-electrophoresis].
Int Arch Allergy Appl Immunol. 1955;7(2):103-10.
3
Albumin turnover in pleural effusions.
Clin Sci. 1965 Oct;29(2):339-52.
4
Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis.
Ann Intern Med. 1972 Mar;76(3):357-63. doi: 10.7326/0003-4819-76-3-357.
6
[Immune reactions during pleural effusions].
Presse Med (1893). 1971 Dec 11;79(53):2421-6.
8
Hypocomplementemia in rheumatoid arthritis.
Arthritis Rheum. 1971 Mar-Apr;14(2):231-8. doi: 10.1002/art.1780140206.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验